LOR.TO Headlines | LORUS THERAPEUTICS INC. Stock - Yahoo! Finance

Wed, Jun 19, 2013, 10:21AM EDT - U.S. Markets close in 5 hrs 39 mins

Dow

0.10% Nasdaq

0.03%

More On LOR.TO

Quotes

Summary
Order Book
Options
Historical Prices

Charts

News & Info

Company

Profile
Key Statistics
SEC Filings
Competitors
Industry
Components

Analyst Coverage

Ownership

Major Holders
Insider Transactions
Insider Roster

Financials

Lorus Therapeutics Inc. (LOR.TO)

-Toronto

0.21 0.00(0.00%) 10:03AM EDT

Add to Portfolio

Headlines

Get Headlines for:

Tuesday, December 4, 2012

Lorus Therapeutics Announces Positive Anticancer Data for IL-17E at AACR Tumor Immunology ConferenceMarketwired (Tue, Dec 4)
Lorus Therapeutics Announces Positive Anticancer Data for IL-17E at AACR Tumor Immunology ConferenceMarketwired (Tue, Dec 4)

Wednesday, November 28, 2012

Lorus Therapeutics 2012 Annual and Special Meeting of Shareholders AnnouncementMarketwired (Wed, Nov 28)
Lorus Therapeutics 2012 Annual and Special Meeting of Shareholders AnnouncementMarketwired (Wed, Nov 28)

Tuesday, November 27, 2012

Cancer Research UK and Lorus to Co-Develop First-Of-Kind Drug, IL-17E, to Treat Solid TumoursMarketwired (Tue, Nov 27)
Cancer Research UK and Lorus to Co-Develop First-Of-Kind Drug, IL-17E, to Treat Solid TumoursMarketwired (Tue, Nov 27)

Monday, October 15, 2012

Lorus Therapeutics Reports First Quarter Results for Fiscal 2013Marketwired (Mon, Oct 15)
Lorus Therapeutics Reports First Quarter Results for Fiscal 2013Marketwired (Mon, Oct 15)
Lorus Therapeutics Reports First Quarter Results for Fiscal 2013Marketwired (Mon, Oct 15)
Lorus Therapeutics Reports First Quarter Results for Fiscal 2013Marketwired (Mon, Oct 15)

Wednesday, October 3, 2012

Lorus Therapeutics to Present at BioContact 2012 in Quebec CityMarketwired (Wed, Oct 3)

Wednesday, August 29, 2012

Lorus Therapeutics Receives Funding from the Government of Canada for Development of Cancer Therapy IL-17EMarketwired (Wed, Aug 29)
Lorus Therapeutics Receives Funding from the Government of Canada for Development of Cancer Therapy IL-17EMarketwired (Wed, Aug 29)
Lorus Therapeutics Receives Funding from the Government of Canada for Development of Cancer Therapy IL-17EMarketwired (Wed, Aug 29)

Monday, August 27, 2012

Lorus Therapeutics to Present at the 14th Annual Rodman & Renshaw Healthcare Conference in New YorkMarketwired (Mon, Aug 27)

Tuesday, August 14, 2012

Lorus Therapeutics Announces Issuance of Patent in Japan for Anticancer Drug LOR-253 and Antimicrobial Drug LOR-220Marketwired (Tue, Aug 14)

Wednesday, August 8, 2012

Lorus Therapeutics Reports Results for Fiscal Year 2012Marketwired (Wed, Aug 8)

Thursday, June 28, 2012

Lorus Therapeutics Announces Issuance of Canadian Patent for Novel Anticancer Therapy IL-17EMarketwired (Thu, Jun 28)

Older Headlines - Most Recent Headlines

Add LOR.TO News to My Yahoo!

Copyright © 2009 Yahoo! All rights reserved.

Quotes are real-time for NASDAQ, NYSE, and NYSE MKT. See also delay times for other exchanges. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein. Real-Time continuous streaming quotes are available through our premium service. You may turn streaming quotes on or off.

Fundamental company data provided by Capital IQ. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). International historical chart data, daily updates, fund summary, fund performance, dividend data and Morningstar Index data provided by Morningstar, Inc.